Clinical characteristics of cytochrome P450 oxidoreductase deficiency: a nationwide survey in Japan
- 1 January 2020
- journal article
- research article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 67 (8), 853-857
- https://doi.org/10.1507/endocrj.ej20-0011
Abstract
Cytochrome P450 oxidoreductase deficiency (PORD) is a disorder of steroidogenesis that causes various symptoms such as skeletal malformations, disorders of sex development, and adrenal insufficiency. The aim of this study was to elucidate the clinical characteristics, especially age at diagnosis and treatment, of PORD from the perinatal period to adulthood in Japan. The first questionnaire was sent to 183 council members of the Japanese Society for Pediatric Endocrinology on 1 September 2018. The response rate was 65%, and a total of 39 patients with PORD were examined at 20 hospitals. The second questionnaire was sent in November 2018 to the council members examining these 39 patients with PORD. The response rate was 77%, and we received clinical information on 30 of the 39 patients. The two novel clinical findings were the age at diagnosis and the treatment of Japanese patients with PORD. In many cases, PORD can be diagnosed at <3 months of age. Hydrocortisone as the primary treatment during infancy can be used daily or in stressful situations; however, because patients with PORD generally have mild to moderate adrenal insufficiency, some might be able to avoid hydrocortisone treatment. Patients with PORD should be carefully followed up, and treatment should be optimized as for patients with other types of adrenal insufficiency. Other characteristics in the present study were similar to those described in previous reports.Keywords
This publication has 13 references indexed in Scilit:
- Classic and non-classic 21-hydroxylase deficiency can be discriminated from P450 oxidoreductase deficiency in Japanese infants by urinary steroid metabolitesClinical Pediatric Endocrinology, 2016
- Cytochrome P450 oxidoreductase deficiency: Rare congenital disorder leading to skeletal malformations and steroidogenic defectsPediatrics International, 2014
- Increased Psychiatric Morbidity in Men With Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyJournal of Clinical Endocrinology & Metabolism, 2014
- Prenatal Diagnosis of Congenital Adrenal Hyperplasia Caused by P450 Oxidoreductase DeficiencyJournal of Clinical Endocrinology & Metabolism, 2013
- Two-Step Biochemical Differential Diagnosis of Classic 21-Hydroxylase Deficiency and Cytochrome P450 Oxidoreductase Deficiency in Japanese Infants by GC-MS Measurement of Urinary Pregnanetriolone/ Tetrahydroxycortisone Ratio and 11β-HydroxyandrosteroneClinical Chemistry, 2012
- Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase DeficiencyJournal of Clinical Endocrinology & Metabolism, 2012
- Pubertal Presentation in Seven Patients with Congenital Adrenal Hyperplasia due to P450 Oxidoreductase DeficiencyJournal of Clinical Endocrinology & Metabolism, 2011
- Cytochrome P450 Oxidoreductase Deficiency: Identification and Characterization of Biallelic Mutations and Genotype-Phenotype Correlations in 35 Japanese PatientsJournal of Clinical Endocrinology & Metabolism, 2009
- Congenital adrenal hyperplasia and P450 oxidoreductase deficiencyClinical Endocrinology, 2006
- Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndromeNature Genetics, 2004